Drug Profile
GSK 568859
Alternative Names: 568859; GSK568859; SB-568859Latest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator Unknown
- Developer GlaxoSmithKline
- Class Cardiovascular therapies
- Mechanism of Action 1-alkyl-2-acetylglycerophosphocholine esterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atherosclerosis
Most Recent Events
- 19 Apr 2011 Discontinued - Phase-I for Atherosclerosis in USA (PO)